Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
aXichem ABOSTO:AXIC A +8.20%66 PS Ratio is 8.82 as of Jul. 21, 2026, which is 92% below its 10-year median of 111.54. GuruFocus rates OSTO:AXIC A with a GF Score™ of 66/100 and a GF Value™ of kr3.59 (Modestly Undervalued). Among 1,574 Chemicals companies, aXichem AB ranks worse than 91.42% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, aXichem AB's share price is kr2.77.
aXichem AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.31. Hence, aXichem AB's PS Ratio for today is 8.82.
The historical rank and industry rank for aXichem AB's PS Ratio or its related term are showing as below:
OSTO:AXIC A'
s PS Ratio Range Over the Past 10 Years
Min: 3.94 Med: 111.54 Max: 7690.35
Current: 8.82
During the past 13 years, aXichem AB's highest PS Ratio was 7690.35. The lowest was 3.94. And the median was 111.54.
OSTO:AXIC A's PS Ratio is ranked worse than 91.42% of 1574
companies
in the Chemicals industry
Industry Median: 1.385
vs OSTO:AXIC A: 8.82
During the past 12 months, the average Revenue per Share Growth Rate of aXichem AB was 30.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 2.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 17.10% per year.
During the past 13 years, aXichem AB's highest 3-Year average Revenue per Share Growth Rate was 140.50% per year. The lowest was -4.70% per year. And the median was 5.90% per year.
Back to Basics: PS Ratio
aXichem AB (OSTO:AXIC A) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
aXichem AB PS Ratio Related Terms
aXichem AB PS Ratio Historical Data
* Premium members only.
The historical data trend for aXichem AB's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, aXichem AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aXichem AB PS Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, aXichem AB's PS Ratio distribution charts can be found below:
* The bar in red indicates where aXichem AB's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
aXichem AB's Share Price of today is kr2.77. aXichem AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.31.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
aXichem AB (OSTO:AXIC A) has a PS Ratio of 8.82 as of Jul. 21, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on aXichem AB and its competitors. This is 92% below median its historical median of 111.54. Over the past decade, aXichem AB's PS Ratio has ranged from 3.94 to 7,690.35. According to the industry distribution chart, aXichem AB ranks #1439 out of 1574 companies in the Chemicals industry, placing it in the top 91.4%.
Is aXichem AB's PS Ratio too high?
aXichem AB's current PS Ratio of 8.82 is 92% below median its 10-year median of 111.54. Over the past 10 years, this metric has ranged from a low of 3.94 to a high of 7,690.35. The Chemicals industry median PS Ratio is 1.39. aXichem AB's value of 8.82 is 536.8% above this industry median. Based on the distribution chart, aXichem AB ranks #1439 out of 1574 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, aXichem AB has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's PS Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, aXichem AB ranks #1439 out of 1574 companies for PS Ratio. This places aXichem AB in the lower half of its industry. The industry median PS Ratio is 1.39. aXichem AB's value of 8.82 is 536.8% above this benchmark. Historically, aXichem AB's own PS Ratio has ranged from 3.94 to 7,690.35 over the past decade. While the company's 10-year median is 111.54 vs. the industry median of 1.39, aXichem AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Chemicals company?
The median PS Ratio among Chemicals companies is 1.39, based on 1,574 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. aXichem AB's current PS Ratio of 8.82 is 536.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on aXichem AB and its competitors. For the Chemicals industry, the median PS Ratio is 1.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aXichem AB's current PS Ratio is 8.82, which is 92% below median its own 10-year median of 111.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
Based on GuruFocus' analysis, aXichem AB (OSTO:AXIC A) is currently considered Modestly Undervalued. The stock's GF Value™ is kr3.59, compared to a current price of kr2.77 — trading 22.8% below its estimated fair value. The current PS Ratio is 8.82, which is 92% below median its 10-year median of 111.54 and 536.8% above the Chemicals industry median of 1.39. aXichem AB's overall GF Score™ is 66/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For aXichem AB (OSTO:AXIC A), the current PS Ratio is 8.82 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aXichem AB (OSTO:AXIC A) Overvalued in 2026?
Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued.
The current stock price of kr2.77 is trading 22.8% below its estimated GF Value™ of kr3.59.
GuruFocus considers aXichem AB to be Modestly Undervalued.
Key valuation signals for OSTO:AXIC A:
PS Ratio: 8.82 (92% below median its 10-year median of 111.54)
GF Value™: kr3.59 vs. price of kr2.77 (22.8% below fair value)
Industry Position: 536.8% above the Chemicals median (#1439 of 1574)
No single metric tells the full story. See the OSTO:AXIC A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
66GF Score
Get the complete analysis for OSTO:AXIC A
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:AXIC A has been successfully added to your 
